Tirzepatide 40mg

Description

A potent 40mg research-grade dual GIP and GLP-1 receptor agonist designed for metabolic and biochemical studies.

Tirzepatide is a novel dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This 40mg lyophilised format is designed for high-capacity laboratory investigations, offering a substantial concentration for long-term experimental protocols. As a synthetic derivative of the gastric inhibitory polypeptide, Tirzepatide’s unique dual-action mechanism is currently a primary focus in metabolic research. In published scientific literature, Tirzepatide has been extensively studied for its synergistic effects on metabolic pathways compared to selective GLP-1 receptor agonists. Researchers utilize this compound to observe its influence on glycemic control mechanisms, lipid metabolism, and energy expenditure in various cellular and animal models. Its ability to activate two distinct incretin pathways simultaneously makes it a cornerstone for studies involving metabolic regulation and hormonal signaling.

Product Overview

Tirzepatide 40mg is a synthetic peptide provided in a stable, lyophilised format. This compound is a 39-amino acid linear peptide that has been chemically modified to enhance its binding affinity to both GIP and GLP-1 receptors. It is intended strictly for in vitro laboratory research and comparative biochemical analysis.

Specifications

Form: Lyophilised Powder Quantity: 40mg Purity: ≥99% (HPLC validated) Storage: Store in a cool, dry place, away from direct light. For long-term stability, maintain at -20°C.

Research Applications

Current research applications for Tirzepatide focus on its dual-agonist properties. Studies typically investigate its role in enhancing insulin secretion sensitivity, reducing glucagon levels, and its impact on appetite-regulating centers in the brain. It is also a subject of interest in research regarding cardiovascular health and non-alcoholic fatty liver disease (NAFLD) models.

Research Use Notice

For laboratory research use only. Not for human or veterinary use.